Researcher
Dr. Joseph Mwangangi
Principal Investigator
KEMRI | Wellcome Trust
About
Dr Joseph Mwangangi is a Senior Principal Research Scientist. Joseph graduated with BSc (Zoology, Botany and Geography) from Kenyatta University, joined KEMRI in 1998. Joseph graduated with a PhD in Medical Entomology from Kenyatta University in 2007. His research interests are malaria vector biology and ecology, novel approaches to the control of vector borne diseases and the monitoring of insecticide resistance. Currently he is working on studies different thematic areas in mosquito biology in the area of larval ecology, malaria transmission dynamics, insecticide resistance and vector control strategies. Joseph is keenly interested in understanding drivers of residual/persistent malaria transmission in endemic areas including entomological, socio-economic, human behavioral aspects. Joseph has strong links to National Malaria Control Programs and supporting the malaria control unit in the national entomological surveillance. He is a member and official of the Pan African Mosquito Control Association (PAMCA).
See moreCurrent Work
His research interests are malaria vector biology and ecology, novel approaches to the control of vector borne diseases and the monitoring of insecticide resistance. Currently he is working on studies different thematic areas in mosquito biology in the area of larval ecology, malaria transmission dynamics, insecticide resistance and vector control strategies. Joseph is keenly interested in understanding drivers of residual/persistent malaria transmission in endemic areas including entomological, socio-economic, human behavioral aspects.
Recent Publications
-
2026
Risk of adverse pregnancy outcomes following inadvertent exposure to ivermectin during the periconception period: findings from two cluster-randomized trials in Mozambique and Kenya
EClinicalMedicine. 2026; 97:104069
-
2026
Risk of adverse pregnancy outcomes following inadvertent exposure to ivermectin during the periconception period: findings from two cluster-randomized trials in Mozambique and Kenya
EClinicalMedicine. 2026; 97:104069
-
2026
Spatial exploration of the impact of cattle on risk of malarial infection using data from a cluster randomised trial
BMJ Glob Health. 2026; 11
-
2026
Community Experiences and Perceptions of the Broad One Health Endectocide-Based Malaria Intervention in Africa Trial of Ivermectin Mass Drug Administration: A Longitudinal Qualitative Study in Kwale County, Kenya
Am J Trop Med Hyg. 2026; 114:72-84
-
2025
MALDI-TOF MS for identification of Afro-tropical secondary malaria vectors
Malar J. 2025; 24:284